Effect of a Nutritional Formula Composed of Proteins and Carbohydrates on Gastric Emptying in Elderly Individuals
1 other identifier
interventional
25
1 country
1
Brief Summary
The objective of this clinical trial is to evaluate the effect of a nutritional formula composed of carbohydrates and proteins on gastric emptying in elderly individuals aged between 60 and 90 years. The main questions this study aims to answer are:
- Does the nutritional formula composed of carbohydrates and proteins delay gastric emptying when compared to a formula composed only of carbohydrates?
- Does the formula composed of carbohydrates and proteins cause gastrointestinal symptoms in the study population? The researchers will compare both formulas (carbohydrates and proteins vs. carbohydrates only) to answer the main question. Participants will be required to:
- Attend the Nuclear Medicine Department after an 8-hour fast, on two separate days with a minimum interval of seven days for scintigraphy procedures.
- Consume the offered formula in a randomized and blinded manner.
- Report any gastrointestinal symptoms and complete visual analog scales for sensations such as hunger, satiety, and desire to eat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2025
CompletedFirst Posted
Study publicly available on registry
December 22, 2025
CompletedStudy Start
First participant enrolled
February 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
May 5, 2026
April 1, 2026
1.2 years
September 26, 2025
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastric Emptying
Gastric emptying will be assessed through scintigraphic imaging obtained immediately after formula consumption and every hour for three hours.
On day 1 and day 2 of the protocol.
Secondary Outcomes (2)
Gastrointestinal symptoms and sensations of hungry, saciety and desire to eat
Immediately after formula ingestion, and at 60, 120, and 180 minutes post-ingestion.
Blood glucose
This assessment will be conducted with the patient in a fasting state, immediately after formula ingestion, and at 60, 120, and 180 minutes post-ingestion on each protocol day.
Study Arms (2)
Formula
EXPERIMENTALIn this arm, participants will undergo scintigraphy after consuming the formula composed of carbohydrates and proteins, over a period of 3 hours (immediately after ingestion and 1 to 3 hours post-ingestion). After the first arm, a 7-day washout period will be implemented
Placebo
PLACEBO COMPARATORIn this arm, participants will undergo scintigraphy after consuming the formula composed only of carbohydrates, over a period of 3 hours (immediately after ingestion and 1 to 3 hours post-ingestion). After the first arm, a 7-day washout period will be implemented.
Interventions
In this intervention, participants will receive 200 ml of the nutritional formula.
In this intervention, participants will receive 200 ml of maltodextrin.
Eligibility Criteria
You may qualify if:
- Elderly individuals aged between 60 and 90 years
- Non-smokers
- No prior diagnosis of conditions that affect gastric emptying, such as:
- Gastroesophageal reflux
- Gastroparesis
- Untreated Helicobacter pylori (H. pylori) infection
- Stomach cancer
- Esophageal cancer
You may not qualify if:
- Refusal to sign the informed consent form (ICF)
- Volunteers with obesity (BMI over 35 kg/m²)
- Volunteers who do not eat orally or have a prior diagnosis of delayed gastric emptying and are on routine use of prokinetic medications
- Individuals diagnosed with Alzheimer's or Parkinson's disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Federal University of Minas Geraislead
- Nestle Health Sciencecollaborator
Study Sites (1)
School of Nursing, Federal University of Minas Gerais
Belo Horizonte, Minas Gerais, 30130-100, Brazil
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Simone de Vasconcelos Generoso Generoso, Phd
Department of Nutrition, Federal University of Minas Gerais
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
September 26, 2025
First Posted
December 22, 2025
Study Start
February 21, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share